[Comparative efficacy of original oil escazole and nemozole suspensions in albino mice with experimental trichinosis in the muscle phase of invasion].

The efficacy of original oil escazole and nemozole suspensions in albino mice in the muscle phase of T. spiralis invasion, which was detected by lifetime diagnosis of experimental trichinosis 6 days after initiation of treatment in a daily dose of 0.3 g/kg, was 100%.

[Efficacy of nocodazole et experimental invasion Echinococcus granulosus of white mice].

The therapeutic activity of subcutaneous and intraperitoneal nocodazole injections was studied in albino mice with experimental E. granulosus invasion. The animals were intraperitoneally infected with Echinococcus larval cysts (ELC) from a spontaneously inoculated sheep.

[Study of the therapeutic activity of nocodazole on experimental models of larval alveococcosis].

The therapeutic activity of parenteral nocodazole was studied on four larval alveococcosis models: golden hamsters (Mesocricetus auratus), Djungarian hamsters (Phodopus sungorus campbelli Thomas), albino rats (Rattus rattus albus), and cotton rats (Sigmodon hispidus) at the late stage of E. multilocularis invasion. The agent (aqueous suspension) was intraperitoneally, intramuscularly, and subcutaneously injected in daily doses of 0.

[Comparative efficacy of albendazole and mebendazole oily suspensions in albino mice with experimental larval alveococcosis].

The comparative efficacy of albendazole and mebendazole oily suspensions (AOS and MOS) was studied in an experimental model of experimental larval alveococcosis in albino mice. The animals were intragastrically injected with the agents once daily for 40 days on day 35 after intraperitoneal inoculation with E. multilocularis acephalocysts.

[Use of an enzyme immunoassay test system with cystic Echinococcus antigen to diagnose echinococcosis alveolaris (multilocularis) (alveococcosis)].

Twenty-three serum samples from 12 patients with Echinococcus alveolaris collected 1 to 12 years after surgery and 1--13 courses of specific therapy were used to evaluate the diagnostic effectiveness of an enzyme immunoassay (EIA) test system with cystic Echinococcus antigen. The findings enable the EIA test system with cystic Echinococcus antigen to be recommended for the diagnosis of Echinococcosis alveolaris and for the monitoring of its treatment results.